Over the course of the campaign, we:
• Gathered 13,703 signatures in support of our call to governments.
• Empowered 8,000 new digital campaigners to support our
advocacy work.
• Gained media coverage across the UK with human storytelling at its
heart.
• Met with 171 MPs in Westminster Parliament influencing 51 MPs to
sign our campaign banner.
• Hosted our first ever Coffee Morning at No.10 Downing Street to make
sure our message was heard loud and clear by decision makers.
• Secured attendance of more than half the total Members of the Senedd to
our Welsh parliamentary Coffee Morning.
• Enabled Macmillan and the campaign to be directly referenced in the First
Minister's Questions in Scotland.
• Delivered a poignant media moment in Northern Ireland with 50 people
living with cancer joining us on the steps of the Senate Chamber at
Stormont to urge decision makers to return to work and address
these issues.
In 2024 we will maintain the momentum of the campaign, while also
supporting people with cancer to advocate for themselves by understanding
how to navigate the complexity of long wait times, and know their rights.
Read more about our 'What Are We Waiting For?' campaign.
Make it easier for people
with cancer to get the
support they need from our
direct and indirect services.
In 2023:
We improved how people with cancer can access support from
healthcare providers.
We know that Macmillan professionals are a vital route for us to reach more
people with cancer and so we launched a new guide to Macmillan services
for healthcare professionals. This was designed to enable professionals to
quickly identify the Macmillan services that can best support the needs of the
patient they are treating - whether that's information about cancer, emotional
or financial support, or seeking support around work. In 2023, we distributed
approximately 3,500 printed guides to healthcare professionals in a variety of
healthcare settings, as well as making it available digitally on our website.
We also developed a navigation strategy to ensure we meet the holistic, nonclinical
needs of people living with cancer. Thank you 26
Environmental, social
and governance review
Financial review
Strategic report
Overview Financial statements
2